2015 American Transplant Congress » Poster Session A: Liver Transplantation: Viral Hepatitis

Date: Saturday, May 2, 2015

Time: 5:30pm-7:30pm

Location: Exhibit Hall E

Session Type: Poster Session

Meeting: 2015 American Transplant Congress

5:30pm-7:30pm: Active Immunization in Patients Transplanted for Hepatitis B Virus Related Liver Diseases: A Preliminary Report of a Prospective Study

W. Ju, A. Yang, Z. Guo, Q. Ren, D. Wang, A. Hu, Y. Ma, H. Jin, X. Zhu, X. He.

5:30pm-7:30pm: Combined Hepatitic/Cholangiopathic Lesion in HIV-HCV Co-Infected Liver Transplant Recipients Associated With Graft Loss

J. Harbell,¹ A. Doherty,² L. Ferrell,² B. Barin,³ N. Terrault,¹ P. Stock.¹

5:30pm-7:30pm: Efficacy of Sofosbuvir Based Therapy for Recurrent Hepatitis C After Liver Transplantation

A. Weick,¹ K. George,¹ S.-M. Jafri,² D. Moonka.²

5:30pm-7:30pm: End of Treatment Liver Biopsy With Sofosbuvir: Histologic Changes Suggestive of Hepatitis C Activity in Liver Transplant Recipients With Achieved SVR

B. Ismail,¹ X. Zervos,¹ P. Bejarano,² M. Waton,¹ D. Beltran,³ D. Sears,¹ A. Tzakis.¹

5:30pm-7:30pm: HCV Treatment in Liver Transplantation: Changes in Center Attitudes and Practices in the DAA Era

A. Shaffer, A. Cash, S. Anjum, D. Segev, C. Durand.

5:30pm-7:30pm: High Tolerability With Sofosbuvir-Based Direct-Acting Antiviral Therapy in Liver Transplant Recipients With Recurrent Hepatitis C

B. Osborne,¹ A. Modi,¹ M. Gautam,¹ N. Murray,¹ I. Gonzalez,² J. McAfee,² S. Gonzalez.¹

5:30pm-7:30pm: Interferon-Free Sofosvir/Ribavirin Treatment Achieves Excellent Sustained Viral Response in Post Liver Transplant HCV Recipients

M. Hamshow, K. Bortecen, R. Layman, A. Winnick, B. Gelb, G. Morgan, L. Teperman.

5:30pm-7:30pm: Long-Term Outcome of Liver Transplant Recipients (OLT) With Hepatitis C Recurrence (HCVR) Who Achieved Postoperative Sustained Virologic Response (SVR) After Combination Antiviral Therapy (Rx) With and Without the Use of Telaprevir (TVR): A Single Center Experience

C. Fasola, P. Mantry, J. Weinstein, H. Nazario, A. Mubarak, M. Barnes, A. Habib, A. Mejia, R. Dickerman, S. Cheng.

5:30pm-7:30pm: Outcomes of Hepatitis C Virus (HCV) Treatment Following Liver Transplantation in the Era of Direct-Acting Antiviral Medications

S. Baggett,¹ D. Jones,¹ M. Shoreibah.²

5:30pm-7:30pm: Sofosbuvir Therapy in Early and Late Post Liver Transplant Setting: A Single Center Experience

X. Zervos,¹ D. Beltran,² B. Ismail,¹ M. Watson,¹ D. Sears,¹ A. Tzakis.¹

5:30pm-7:30pm: Sofosbuvir-Based Therapy for Hepatitis C Recurrence Post Liver Transplantation

A. Ajlan,¹ A. Aljedai,¹ H. Elsiesy,² D. Alkortas,¹ R. Alarieh,² F. Aba Alkhail.²

« View all sessions from the 2015 American Transplant Congress